Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease

Jiunn Diann Lin, Yuan Hung Wang, Wen Fang Fang, Chia Jung Hsiao, Amarzaya Chagnaadorj, Yuh Feng Lin, Kam Tsun Tang, Chao Wen Cheng

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background This study investigated the association of serum B-lymphocyte activating factor (BAFF) levels with autoimmune thyroid disease (AITD) in a Chinese population. Materials and methods We enrolled 221 patients with AITD [170 patients with Graves' disease (GD), 51 patients with Hashimoto's thyroiditis (HT)], and 124 healthy controls. Serum BAFF levels, thyroid function and thyroid autoantibody (TAb) levels, including of thyroid-stimulating hormone receptor antibody (TSHRAb), anti-thyroid peroxidase antibody (Anti-TPO Ab), and antithyroglobulin antibody (ATA), were measured at baseline. Results Serum BAFF levels were higher in the GD, HT, and AITD groups than in the control group. Significant correlations were observed between BAFF and TSHRAb levels (r = 0.238, p = 0.018), between BAFF and Anti-TPO Ab levels (p = 0.038), and between BAFF and ATA titers (p = 0.025) in women but not in men. In addition, serum BAFF levels were significantly associated with free thyroxine (r = 0.430, p = 0.004) and TSHRAb (r = 0.495, p = 0.001) levels in women with active GD but not in those with inactive GD. Conclusions Serum BAFF levels are increased in GD, HT, and AITD. The correlation between serum BAFF and TAb levels exhibits a dimorphic pattern, particularly in active GD.

Original languageEnglish
Pages (from-to)96-102
Number of pages7
JournalClinica Chimica Acta
Volume462
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Graves Disease
Thyroid Diseases
Autoantibodies
Autoimmune Diseases
Thyroid Gland
Thyrotropin Receptors
Hashimoto Disease
Serum
Iodide Peroxidase
Antibodies
B-Cell Activating Factor
Thyroxine
Anti-Idiotypic Antibodies
Control Groups
Population

Keywords

  • Autoantibody
  • Autoimmune thyroid disease
  • B-lymphocyte activating factor
  • Graves' disease
  • Hashimoto's thyroiditis

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease. / Lin, Jiunn Diann; Wang, Yuan Hung; Fang, Wen Fang; Hsiao, Chia Jung; Chagnaadorj, Amarzaya; Lin, Yuh Feng; Tang, Kam Tsun; Cheng, Chao Wen.

In: Clinica Chimica Acta, Vol. 462, 01.11.2016, p. 96-102.

Research output: Contribution to journalArticle

Lin, Jiunn Diann ; Wang, Yuan Hung ; Fang, Wen Fang ; Hsiao, Chia Jung ; Chagnaadorj, Amarzaya ; Lin, Yuh Feng ; Tang, Kam Tsun ; Cheng, Chao Wen. / Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease. In: Clinica Chimica Acta. 2016 ; Vol. 462. pp. 96-102.
@article{db1e4beaa02a40ec9638338ef5ba2f0f,
title = "Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease",
abstract = "Background This study investigated the association of serum B-lymphocyte activating factor (BAFF) levels with autoimmune thyroid disease (AITD) in a Chinese population. Materials and methods We enrolled 221 patients with AITD [170 patients with Graves' disease (GD), 51 patients with Hashimoto's thyroiditis (HT)], and 124 healthy controls. Serum BAFF levels, thyroid function and thyroid autoantibody (TAb) levels, including of thyroid-stimulating hormone receptor antibody (TSHRAb), anti-thyroid peroxidase antibody (Anti-TPO Ab), and antithyroglobulin antibody (ATA), were measured at baseline. Results Serum BAFF levels were higher in the GD, HT, and AITD groups than in the control group. Significant correlations were observed between BAFF and TSHRAb levels (r = 0.238, p = 0.018), between BAFF and Anti-TPO Ab levels (p = 0.038), and between BAFF and ATA titers (p = 0.025) in women but not in men. In addition, serum BAFF levels were significantly associated with free thyroxine (r = 0.430, p = 0.004) and TSHRAb (r = 0.495, p = 0.001) levels in women with active GD but not in those with inactive GD. Conclusions Serum BAFF levels are increased in GD, HT, and AITD. The correlation between serum BAFF and TAb levels exhibits a dimorphic pattern, particularly in active GD.",
keywords = "Autoantibody, Autoimmune thyroid disease, B-lymphocyte activating factor, Graves' disease, Hashimoto's thyroiditis",
author = "Lin, {Jiunn Diann} and Wang, {Yuan Hung} and Fang, {Wen Fang} and Hsiao, {Chia Jung} and Amarzaya Chagnaadorj and Lin, {Yuh Feng} and Tang, {Kam Tsun} and Cheng, {Chao Wen}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.cca.2016.09.004",
language = "English",
volume = "462",
pages = "96--102",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease

AU - Lin, Jiunn Diann

AU - Wang, Yuan Hung

AU - Fang, Wen Fang

AU - Hsiao, Chia Jung

AU - Chagnaadorj, Amarzaya

AU - Lin, Yuh Feng

AU - Tang, Kam Tsun

AU - Cheng, Chao Wen

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background This study investigated the association of serum B-lymphocyte activating factor (BAFF) levels with autoimmune thyroid disease (AITD) in a Chinese population. Materials and methods We enrolled 221 patients with AITD [170 patients with Graves' disease (GD), 51 patients with Hashimoto's thyroiditis (HT)], and 124 healthy controls. Serum BAFF levels, thyroid function and thyroid autoantibody (TAb) levels, including of thyroid-stimulating hormone receptor antibody (TSHRAb), anti-thyroid peroxidase antibody (Anti-TPO Ab), and antithyroglobulin antibody (ATA), were measured at baseline. Results Serum BAFF levels were higher in the GD, HT, and AITD groups than in the control group. Significant correlations were observed between BAFF and TSHRAb levels (r = 0.238, p = 0.018), between BAFF and Anti-TPO Ab levels (p = 0.038), and between BAFF and ATA titers (p = 0.025) in women but not in men. In addition, serum BAFF levels were significantly associated with free thyroxine (r = 0.430, p = 0.004) and TSHRAb (r = 0.495, p = 0.001) levels in women with active GD but not in those with inactive GD. Conclusions Serum BAFF levels are increased in GD, HT, and AITD. The correlation between serum BAFF and TAb levels exhibits a dimorphic pattern, particularly in active GD.

AB - Background This study investigated the association of serum B-lymphocyte activating factor (BAFF) levels with autoimmune thyroid disease (AITD) in a Chinese population. Materials and methods We enrolled 221 patients with AITD [170 patients with Graves' disease (GD), 51 patients with Hashimoto's thyroiditis (HT)], and 124 healthy controls. Serum BAFF levels, thyroid function and thyroid autoantibody (TAb) levels, including of thyroid-stimulating hormone receptor antibody (TSHRAb), anti-thyroid peroxidase antibody (Anti-TPO Ab), and antithyroglobulin antibody (ATA), were measured at baseline. Results Serum BAFF levels were higher in the GD, HT, and AITD groups than in the control group. Significant correlations were observed between BAFF and TSHRAb levels (r = 0.238, p = 0.018), between BAFF and Anti-TPO Ab levels (p = 0.038), and between BAFF and ATA titers (p = 0.025) in women but not in men. In addition, serum BAFF levels were significantly associated with free thyroxine (r = 0.430, p = 0.004) and TSHRAb (r = 0.495, p = 0.001) levels in women with active GD but not in those with inactive GD. Conclusions Serum BAFF levels are increased in GD, HT, and AITD. The correlation between serum BAFF and TAb levels exhibits a dimorphic pattern, particularly in active GD.

KW - Autoantibody

KW - Autoimmune thyroid disease

KW - B-lymphocyte activating factor

KW - Graves' disease

KW - Hashimoto's thyroiditis

UR - http://www.scopus.com/inward/record.url?scp=84988027191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988027191&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2016.09.004

DO - 10.1016/j.cca.2016.09.004

M3 - Article

C2 - 27616625

AN - SCOPUS:84988027191

VL - 462

SP - 96

EP - 102

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -